<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108424-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Evaluation of South Africa&#x2019;s excise tax on sugar-sweetened beverages</narrative>
   <narrative xml:lang="FR">&#xC9;valuation de l&#x2019;application par l&#x2019;Afrique du Sud d&#x2019;une taxe d&#x2019;accise sur les boissons sucr&#xE9;es</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Les maladies non transmissibles, qui contribuent de fa&#xE7;on marqu&#xE9;e &#xE0; la charge de morbidit&#xE9; de l&#x2019;Afrique du Sud sont largement caus&#xE9;es par l&#x2019;ob&#xE9;sit&#xE9; et les maladies associ&#xE9;es. La pr&#xE9;valence de l&#x2019;ob&#xE9;sit&#xE9; a augment&#xE9; de 30 % pendant la derni&#xE8;re d&#xE9;cennie, tandis que la consommation d&#x2019;aliments &#xE0; haute teneur en &#xE9;nergie, et ultratransform&#xE9;s s&#x2019;est accrue consid&#xE9;rablement, les ventes de boissons sucr&#xE9;es ayant connu une hausse de plus de 50 %. Reconnaissant la gravit&#xE9; croissante de cette &#xE9;pid&#xE9;mie, le gouvernement a &#xE9;labor&#xE9; une strat&#xE9;gie de pr&#xE9;vention de l&#x2019;ob&#xE9;sit&#xE9; qui comprend notamment l&#x2019;application annonc&#xE9;e r&#xE9;cemment d&#x2019;une taxe d&#x2019;accise sur les boissons sucr&#xE9;es. 

M&#xEA;me s&#x2019;il semble de plus en plus &#xE9;tabli que ce type de taxe contribue efficacement &#xE0; r&#xE9;duire la consommation dans les pays d&#xE9;velopp&#xE9;s, les intervenants vis&#xE9;s ont fait valoir que la taxe en question n&#x2019;aurait aucune efficacit&#xE9; et qu&#x2019;elle impose un fardeau indu aux entreprises sud-africaines. La surveillance de son effet sur la consommation et la preuve que son incidence est mesurable sont les facteurs susceptibles de d&#xE9;terminer si cette taxe visant &#xE0; obtenir des gains optimaux en mati&#xE8;re de sant&#xE9; sera mise en oeuvre de fa&#xE7;on effective et continue. 

Le projet consistera &#xE0; effectuer une &#xE9;valuation globale des effets de cette nouvelle politique en Afrique du Sud. Il comportera quatre volets qui serviront &#xE0; documenter et &#xE0; &#xE9;tudier le contexte socio&#xE9;conomique justifiant l&#x2019;application d&#x2019;une taxe sur les boissons sucr&#xE9;es et d&#x2019;entreprendre d&#x2019;autres initiatives de pr&#xE9;vention de l&#x2019;ob&#xE9;sit&#xE9;; la r&#xE9;action des consommateurs face &#xE0; la taxe; la r&#xE9;action des producteurs face &#xE0; cette m&#xEA;me taxe; ainsi que les impacts sur la protection de la sant&#xE9; et les risques financiers li&#xE9;s &#xE0; la taxe selon divers niveaux de revenu. 

Le projet consistera en une initiative multidisciplinaire comprenant des m&#xE9;thodes tant quantitatives que qualitatives, comme les &#xE9;tudes &#xE9;conom&#xE9;triques, les sondages et les entrevues en profondeur. Il produira des connaissances pertinentes pour de nombreux secteurs du gouvernement et de la soci&#xE9;t&#xE9;. Il contribuera &#xE0; constituer la nouvelle base de connaissances sur l&#x2019;efficacit&#xE9; des politiques fiscales pour la pr&#xE9;vention des maladies non transmissibles dans les pays &#xE0; revenu faible et interm&#xE9;diaire.</narrative>
   <narrative xml:lang="EN">Non-communicable diseases, which contribute significantly to South Africa&#x2019;s disease burden, are largely driven by obesity and associated illnesses. Obesity prevalence has increased by 30% over the last decade, while consumption of energy-dense, ultra-processed foods and beverages has grown substantially, with sales of sugar-sweetened beverages increasing by more than 50%. Recognizing the growing severity of this epidemic, the government has devised an obesity prevention strategy, which includes a recently announced excise tax on sugar-sweetened beverages. 

Despite growing evidence that such taxation is effective in reducing consumption in developing country settings, interested stakeholders have argued that the tax will not be effective and will impose an undue burden on businesses in South Africa. The effective and continued implementation of this tax to achieve optimal health gains will thus hinge on whether or not its effect on consumption is monitored and its impact is demonstrable. 

The project will undertake a holistic assessment of the effects of this novel policy in South Africa. It will adopt a four-pronged approach, which will document and investigate the socioeconomic context justifying the need for sugar-sweetened beverage taxation and other obesity-prevention efforts; the consumers&#x2019; response to the tax; the producers&#x2019; response to the tax; and the health and financial risk protection impacts of the tax across different levels of income. 

The project will be a multi-disciplinary effort incorporating both quantitative and qualitative methods such as econometric studies, surveys, and in-depth interviews. The project will produce relevant knowledge for multiple sectors of government and society. It will help to build the emerging knowledge base on the effectiveness of taxation policies for non-communicable disease prevention in low- and middle-income countries.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="22">
   <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
  </participating-org>
  <participating-org role="4" type="22">
   <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-03-01" type="2"></activity-date>
  <activity-date iso-date="2020-09-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ZA" percentage="100"></recipient-country>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12110" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-02-16"></transaction-date>
   <value currency="CAD" value-date="2017-02-16">1022900</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-02-17"></transaction-date>
   <value currency="CAD" value-date="2017-02-17">135050</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-08-31"></transaction-date>
   <value currency="CAD" value-date="2017-08-31">135050</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-05-29"></transaction-date>
   <value currency="CAD" value-date="2018-05-29">255610</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-08-16"></transaction-date>
   <value currency="CAD" value-date="2018-08-16">255609</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-07-15"></transaction-date>
   <value currency="CAD" value-date="2019-07-15">100000</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-09-10"></transaction-date>
   <value currency="CAD" value-date="2019-09-10">69362</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-950681</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">950681</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
